Cellular aging and cancer

Critical Reviews in Oncology/Hematology

Volumn 79, Issue 2, 2011, Pages 189-195

  Hornsby, Peter J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aging; Cancer development; Crisis; Experimental tumorigenesis; Inflammation; Innate immunity; Senescence; Telomeres; Tumor suppression

Indexed keywords

HISTONE H2AX; MYC PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR E2F; VIRUS LARGE T ANTIGEN;

CARCINOGENESIS; CELL AGING; CELL CLONE; CELL FUSION; CHROMOSOME STRUCTURE; ENZYME ACTIVITY; GENE ACTIVATION; HUMAN; IN VIVO CULTURE; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; REVIEW; TELOMERE; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA DAMAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; MICE; MICE, NUDE; NEOPLASMS; ONCOGENES; TELOMERASE; TELOMERE; TUMOR SUPPRESSOR PROTEINS;

EID: 79960187460     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.07.011     Document Type: Review

References (73)

1. Peto R., Parish S.E., Gray R.G. There is no such thing as ageing and cancer is not related to it. Age-related factors in carcinogenesis 1985, 43-53. International Agency for Research on Cancer, Lyon. A. Likhachev, V.N. Anisimov, R. Montesano (Eds.).
2. Hayflick L. Cell aging. Annu Rev Gerontol Geriatr 1980, 1:26-67.
3. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
4. Allsopp R.C., Vaziri H., Patterson C., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89:10114-10118.
5. Greider C.W. Telomeres, telomerase and senescence. Bioessays 1990, 12:363-369.
6. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991, 256:271-282.
7. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997, 276:561-567.
8. Meyerson M., Counter C.M., Eaton E.N., et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795.
9. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 2009, 11:59-98.
10. Narita M., Nunez S., Heard E., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
11. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
12. Acilan C., Potter D.M., Saunders W.S. DNA repair pathways involved in anaphase bridge formation. Genes Chromosomes Cancer 2007, 46:522-531.
13. Roninson I.B., Broude E.V., Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001, 4:303-313.
14. Guiducci C., Cerone M.A., Bacchetti S. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene 2001, 20:714-725.
15. Gisselsson D., Jonson T., Petersen A., et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 2001, 98:12683-12688.
16. Gisselsson D., Bjork J., Hoglund M., et al. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 2001, 158:199-206.
17. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 2002, 297:565-569.
18. DePinho R.A., Wong K.K. The age of cancer: telomeres, checkpoints, and longevity. J Clin Invest 2003, 111:S9-S14.
19. Gisselsson D. Chromosome instability in cancer: how, when, and why?. Adv Cancer Res 2003, 87:1-29.
20. Sun B., Chen M., Hawks C.L., Pereira-Smith O.M., Hornsby P.J. The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay. Neoplasia 2005, 7:585-593.
21. Livingston D.M., Bradley M.K. The simian virus 40 large T antigen. A lot packed into a little. Mol Biol Med 1987, 4:63-80.
22. Fanning P. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol 1992, 66:1289-1293.
23. Boettner B., Van Aelst L. The RASputin effect. Genes Dev 2002, 16:2033-2038.
24. Sun B., Huang Q., Liu S., et al. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase. Cancer Res 2004, 64:6144-6151.
25. Liang S., Kahlenberg M.S., Rousseau D.L., Hornsby P.J. Neoplastic conversion of human colon smooth muscle cells: no requirement for telomerase. Mol Carcinog 2008, 47:478-484.
26. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468.
27. Sun B., Chen M., Hawks C.L., Hornsby P.J. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation. Cancer Res 2005, 65:6512-6515.
28. Hornsby P.J. Cell proliferation in mammalian aging. Handbook of the biology of aging 2001, 207-266. Academic Press, San Diego. 5th ed. E.J. Masoro, S.N. Austad (Eds.).
29. Martin G.M., Sprague C.A., Epstein C.A. Replicative life-span of cultivated human cells: effects of donor's age, tissue and genotype. Lab Invest 1970, 23:86-92.
30. Goldstein S., Moerman E.J., Soeldner J.S., Gleason R.E., Barnett D.M. Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science 1978, 199:781-782.
31. Gilchrest B.A. Prior chronic sun exposure decreases the lifespan of human skin fibroblasts in vitro. J Gerontol 1980, 35:537-541.
32. Cristofalo V.J., Allen R.G., Pignolo R.J., Martin B.G., Beck J.C. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 1998, 95:10614-10619.
33. Mitchell J.R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999, 402:551-555.
34. Vulliamy T., Marrone A., Goldman F., et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001, 413:432-435.
35. Marciniak R.A., Johnson F.B., Guarente L. Dyskeratosis congenita, telomeres and human ageing. Trends Genet 2000, 16:193-195.
36. O'Sullivan J.N., Bronner M.P., Brentnall T.A., et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284.
37. Kammori M., Poon S.S., Nakamura K., et al. Squamous cell carcinomas of the esophagus arise from a telomere-shortened epithelial field. Int J Mol Med 2007, 20:793-799.
38. Aida J., Izumo T., Shimomura N., et al. Telomere lengths in the oral epithelia with and without carcinoma. Eur J Cancer 2009, 46:430-438.
39. Hornsby P.J. Senescence as an anticancer mechanism. J Clin Oncol 2007, 25:1852-1857.
40. Dimri G.P., Lee X.H., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367.
41. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
42. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 2007, 128:36-44.
43. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts - a model for senescence. Exp Cell Res 1995, 220:186-193.
44. Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszek M.A., Shay J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995, 1:249-255.
45. Gordon K.E., Ireland H., Roberts M., et al. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. Cancer Res 2003, 63:458-467.
46. Neumann A.A., Reddel R.R. Telomere maintenance and cancer - look, no telomerase. Nat Rev Cancer 2002, 2:879-884.
47. Kyo S., Takakura M., Fujiwara T., Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008, 99:1528-1538.
48. Cesare A.J., Reddel R.R. Telomere uncapping and alternative lengthening of telomeres. Mech Ageing Dev 2008, 129:99-108.
49. Serrano M., Lin A.W., Mccurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16 INK4A. Cell 1997, 88:593-602.
50. Collado M., Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006, 6:472-476.
51. Mooi W.J., Peeper D.S. Oncogene-induced cell senescence - halting on the road to cancer. N Engl J Med 2006, 355:1037-1046.
52. Pollock P.M., Harper U.L., Hansen K.S., et al. High frequency of BRAF mutations in nevi. Nat Genet 2003, 33:19-20.
53. E600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724.
54. Sithanandam G., Kolch W., Duh F.M., Rapp U.R. Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. Oncogene 1990, 5:1775-1780.
55. Frame F.M., Rogoff H.A., Pickering M.T., Cress W.D., Kowalik T.F. E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts. Oncogene 2006, 25:3258-3266.
56. Abulaiti A., Fikaris A.J., Tsygankova O.M., Meinkoth J.L. Ras induces chromosome instability and abrogation of the DNA damage response. Cancer Res 2006, 66:10505-10512.
57. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434:907-913.
58. Bartkova J., Horejsi Z., Koed K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
59. Davis T., Baird D.M., Haughton M.F., Jones C.J., Kipling D. Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol 2005, 60A:1386-1393.
60. Hong S., Pusapati R.V., Powers J.T., Johnson D.G. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis. Cell Cycle 2006, 5:801-803.
61. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008, 8:512-522.
62. Evan G.I., d'Adda di Fagagna F. Cellular senescence: hot or what?. Curr Opin Genet Dev 2009, 19:25-31.
63. Fumagalli M., d'Adda di Fagagna F. SASPense and DDRama in cancer and ageing. Nat Cell Biol 2009, 11:921-923.
64. Kuilman T., Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009, 9:81-94.
65. Ren J.L., Pan J.S., Lu Y.P., Sun P., Han J. Inflammatory signaling and cellular senescence. Cell Signal 2009, 21:378-383.
66. Soriani A., Zingoni A., Cerboni C., et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009, 113:3503-3511.
67. Bataille V., Kato B.S., Falchi M., et al. Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 2007, 16:1499-1502.
68. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
69. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
70. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001, 98:12072-12077.
71. Liu D., Hornsby P.J. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 2007, 67:3117-3126.
72. Walter M., Liang S., Ghosh S., Hornsby P.J., Li R. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 2009, 28:2745-2755.
73. Liu D., Hornsby P.J. Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect. Neoplasia 2007, 9:418-426.